This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovator Spotlight: Peter Peng and His Contributions to Cancer Treatment
Introduction: Peter Peng is a notable inventor based in Baltimore, MD, whose innovative work in the field of immunotherapy has garnered attention for its potential in cancer treatment. With a focus on T cell receptors, his invention aims to revolutionize how cancer is detected and treated, marking a significant milestone in medical research.
Latest Patents: Peter Peng holds one patent for his work on T cell receptors and related materials and methods of use. This invention provides T cell receptors (TCRs) with antigenic specificity for cancer antigens such as tyrosinase. In addition to TCRs, the patent covers related polypeptides, proteins, nucleic acids, recombinant expression vectors, isolated host cells, populations of cells, and pharmaceutical compositions. The invention also details methods for detecting cancer presence in a host and offers a new approach for treating or preventing cancer using the inventive materials.
Career Highlights: Peter is currently employed by the United States of America as represented by the Secretary of the Department of Health and Human Services. He has played a crucial role in advancing cancer research, contributing to the development of innovative treatments that leverage the body's immune system.
Collaborations: Throughout his career, Peter has collaborated with esteemed colleagues, including Steven A. Rosenberg and Richard A. Morgan. These partnerships reflect a commitment to advancing medical science and developing effective cancer therapies, utilizing their collective expertise to push boundaries in the field.
Conclusion: Peter Peng stands out as a key inventor in the realm of cancer treatment innovations. His patent for T cell receptors not only signifies a breakthrough in cancer detection and treatment but also highlights the importance of collaboration in scientific progress. As researchers continue to build upon his foundations, the potential for improved therapies in battling cancer remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile